# Magnesium Supplementation and Blood Pressure Reduction

> **NCT03688503** · NA · COMPLETED · sponsor: **Brigham and Women's Hospital** · enrollment: 59 (actual)

## Conditions studied

- Blood Pressure

## Interventions

- **DIETARY_SUPPLEMENT:** magnesium glycinate supplement
- **DIETARY_SUPPLEMENT:** placebo

## Key facts

- **NCT ID:** NCT03688503
- **Lead sponsor:** Brigham and Women's Hospital
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2019-02-15
- **Primary completion:** 2020-01-09
- **Final completion:** 2025-08-15
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2025-10-01

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03688503

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03688503, "Magnesium Supplementation and Blood Pressure Reduction". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03688503. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*
